GlassScriptPhysician profile
Hassan S Makki
NPI 1114133261
$13,989.30
in general payments reported to CMS, 2019-2025
27 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,541 · 2020: $565 · 2021: $8,110 · 2022: $771 · 2023: $677 · 2024: $842 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,378 · Travel and Lodging: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,378.02 |
| Travel and Lodging | $625.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $7,583.22 | 2020-2023 | Auryon Laser System 100-120 Vac |
| Abbott Laboratories | $2,864.73 | 2019-2024 | Gallant, Assurity, Jot Dx |
| Medtronic, INC. | $811.36 | 2022-2025 | Turbohawk, Abre, Hawkone |
| Ekos Corporation | $632.69 | 2019 | |
| Cardiovascular Systems INC. | $310.38 | 2019 | |
| Medtronic Vascular, INC. | $266.59 | 2019-2020 | |
| Boston Scientific Corporation | $261.24 | 2020-2025 | Latitude Communicator Power Supply, Watchman Access System, Cds - Mct/Cem Monitoring |
| Nevro Corp. | $149.08 | 2022 | |
| Koya Medical, INC. | $127.46 | 2024 | Dayspring, Koya Medical |
| Surmodics, INC. | $126.37 | 2023 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Biosense Webster, INC. | $117.27 | 2019 | |
| Tactile Systems Technology INC | $100.34 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $90.60 | 2019-2022 | |
| Cardiva Medical, INC. | $68.49 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $66.85 | 2019-2024 | Lifevest |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $60.01 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $57.94 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $51.19 | 2022-2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $50.20 | 2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $37.36 | 2024-2025 | Camzyos, Eliquis |
| Livanova USA, INC. | $26.15 | 2023 | Lifesparc |
| Abiomed | $25.50 | 2023 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.77 | 2021 | |
| Chiesi USA, INC. | $24.30 | 2025 | Juxtapid |
| Viiv Healthcare Company | $21.26 | 2025 | Apretude |
| Alnylam Pharmaceuticals INC. | $19.71 | 2024 | Amvuttra |
| Smith+Nephew, INC. | $14.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hassan Makki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.